Want to join the conversation?
$NWL 2Q15 Q&A: Olivia, BofA: On the organic revenue growth outlook, can you provide a bit other factors we should be thinking about for the second half? John, CFO: Expect Writing to decelerate in Q4, partially offset by Tools acceleration in the back half of the year. It's really tough to be precise, but that's a deliberate choice.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)